| ADR | Adriamycin |
| APIs | Active pharmaceutical ingredient |
| AML | Acute myeloid leukemia |
| AMPK | 5′ Adenosine monophosphate-activated protein kinase |
| APIs | Active pharmaceutical ingredients |
| BW | Body weight |
| BBB | Blood–brain barrier |
| CAM | Camphor |
| CAP | Capric acid |
| CV | Carvacrol |
| CVN | Carvone |
| CoN | Colon epithelial cells |
| COX-2 | Cyclooxygenase-2 |
| cSLNs | Cationic solid lipid nanoparticles |
| DEN | Diethylnitrosamine |
| DESs | Deep eutectic solvents |
| DMBA | 7,12-Dimethylbenz[a]anthracene |
| DMH | 1,2-Dimethylhydrazine |
| EC50 | Effective concentration of a drug or concentration of a drug which is calculated to inhibit virus induced cell death by 50% |
| ERK | Extracellular signal-regulated kinases |
| EU | Eucalyptol |
| GBA | Glioblastoma |
| GI50 | The 50% growth inhibition percentage |
| GI% | The cell growth inhibition percentage values |
| HBAs | Hydrogen bond acceptors |
| HC | Hepatocellular carcinoma |
| HDFs | Human dermal fibroblasts |
| HRPC | Hormone-refractory prostate cancer |
| IBU | Ibuprofen |
| IC50 | Concentration of an inhibitor where the response (or binding) is reduced by half |
| LIM | limonene |
| LIM-SLNs | Solid lipid nanoparticles formulation with (+)-limonene 1,2-epoxide and glycerol monostearate |
| LPO | Lipid peroxidation |
| MAPK | Mitogen-activated protein kinase |
| MA | Myristic acid |
| ME | Menthol |
| MTT | 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide |
| MTT assay | The colorimetric assay based on the reduction of yellow tetrazolium salt (MTT) to purple formazan |
| NADESs | Natural deep eutectic systems |
| NEO100 | Highly pure perillyl alcohol |
| NR | 3-Amino-7-dimethyl-2-methylphenazine hydrochloride |
| NR assay | The neutral red (NR) dye uptake assay |
| NEO212 | Compound built of perillyl alcohol and temozolomide |
| p21waf1 | Cyclin-dependent kinase inhibitor |
| PAH | Perillaldehyde |
| 3-PCA | Pyrrolidine-3-carboxylic acid |
| PE | Perillaldehyde 1,2-epoxide |
| PLK1 | Polo-like kinase 1 |
| PM | Physical mixtures |
| POH | Perillyl alcohol |
| ROS | Reactive oxygen species |
| SLNs | Solid lipid nanoparticles |
| SRB | Sulforhodamine B |
| SAR | Structure-activity relationship |
| THEDES | Therapeutic deep eutectic system |
| THEDESs | Therapeutic deep eutectic solvents |
| TMZ | Temozolomide |
| TRPM8 | Transient receptor potential melastatin member 8 |